PubMed=8548765
Lin K.-Y., Guarnieri F.G., Staveley-O'Carroll K.F., Levitsky H.I., August J.T., Pardoll D.M., Wu T.-C.
Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.
Cancer Res. 56:21-26(1996)
PubMed=12559790; DOI=10.1016/s0264-410x(02)00519-4
Smahel M., Sima P., Ludvikova V., Marinov I., Pokorna D., Vonka V.
Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules.
Vaccine 21:1125-1136(2003)
PubMed=31638243; DOI=10.3892/or.2019.7356
Lhotakova K., Grzelak A., Polakova I., Vackova J., Smahel M.
Establishment and characterization of a mouse tumor cell line with irreversible downregulation of MHC class I molecules.
Oncol. Rep. 42:2826-2835(2019)